Needham raised the firm’s price target on Glaukos (GKOS) to $136 from $127 and keeps a Buy rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GKOS:
- Glaukos price target raised to $140 from $135 at Citi
- Glaukos Reaffirmed as Buy on Strong Q1 Beat, Raised 2026 Revenue Outlook, and Billion-Dollar Peak Potential for iDose and Epioxa
- Glaukos reports Q1 EPS (18c), consensus (28c)
- Glaukos sees FY26 revenue $620M-$635M, consensus $614.4M
- Glaukos Boosts Outlook After Strong First-Quarter 2026 Results